Built on decades of science, algorithms refined by real-world data from thousands of patients, and Senzime’s proprietary Level-of-Block Gauge, the next-generation TetraGraph is a game changer in neuromuscular monitoring.

Highlights of the new EMGINE software suite include:

1. TetraGraph just got even smarter. Introducing Senzime’s 7^th-generation EMG monitoring algorithm refined to provide further clinical perfection using over 6 billion real-world datapoints.

2. Powered by TetraGraph Adaptive Intelligence^TM. Advanced quantitative train-of-four (TOF) monitoring made simple – enhancing patient safety and supporting hospitals in achieving compliance to international guidelines.

3. Optimized with unique noise-reduction technology. Ensures consistent, reliable, and accurate data even amidst disturbances in the modern operating room.

“Senzime continues to lead the development of neuromuscular monitoring with science, innovation and patient safety at the forefront. With our latest generation of TetraGraph, we provide users with continuous access to the most advanced technology and the latest clinical insights on the market. New features are continuously developed in close collaboration with world-leading anesthesiologists and are based on real-world data collected from clinics around the globe. Since the launch of the next-generation TetraGraph platform in late 2024, nearly two thousand operating rooms have already upgraded. We also offer the industry’s most comprehensive and flexible connectivity solutions with seamless integration to patient monitors and electronic health records, cloud-based data analysis, and clinical support that help hospitals stay at the forefront of the latest clinical guidelines,” said Philip Siberg, CEO of Senzime.

The Senzime TetraGraph system is used by anesthesiologists in thousands of operating rooms at university, veterans’, public, and private hospitals worldwide to enhance patient safety during and after surgery. The system monitors patients’ neuromuscular function in real time, ensuring accurate dosing of neuromuscular blocking agents and reversal drugs, and helping clinicians to determine when it is safe for patients to resume spontaneous breathing after surgery.

Senzime will showcase the next-generation TetraGraph system and the new EMGINE software in their booth #1531 at the ANETHESIOLOGY^® 2025 congress in San Antonio, October 11-13, 2025. The new EMGINE software ships with all new TetraGraph monitors and is available to all existing users via a simple upgrade.

More information about TetraGraph is available at https://www.senzime.com/nextgen
Press images are available at https://www.senzime.com/en/media-toolkit